Patent directory · USPTO A61K / A61P
Patents matching “GLP-1”
15 pharma patents match "GLP-1" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 15 pharmaceutical patents matching "GLP-1" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
WO 2025252715
AGONISTE DOUBLE DU RÉCEPTEUR DU GLP-1 ET DU GLUCAGON POUR LE TRAITEMENT DE LA MASH ET DE LA CIRRHOSE
granted -
US 12291530
GLP-1R agonist and therapeutic method thereof
granted -
US 12234236
GLP-1R agonist and therapeutic method thereof
granted -
US 12215133
GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use
granted -
US 12145974
Dual-target fusion proteins comprising FGF21 and GLP-1, connected through a Fc portion of an immunoglobulin
granted -
US 12115225
GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof
granted -
US 10941187
GLP-1, exendin-4, peptide analogs and uses thereof
granted -
US 8853160
GLP-1, exendin-4, peptide analogs and uses thereof
granted -
US 8580919
Polymer conjugates of GLP-1
granted -
US 8293869
Polymer conjugates of GLP-1
granted -
US 8278272
GLP-1, exendin-4, peptide analogs and uses thereof
granted -
US 7576050
GLP-1 exendin-4 peptide analogs and uses thereof
granted -
US 7276352
Induction of β cell differentiation in human cells by stimulation of the GLP-1 receptor
granted -
US 7056734
Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof
granted -
US 6884585
Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor
expired